高级检索
    陈治宇, 黎莹. 强强联合,持久获益——系统性治疗失败的MSI-H/dMMR转移性结直肠癌的免疫联合治疗[J]. 循证医学, 2020, 20(4): 222-226. DOI: 10.12019/j.issn.1671-5144.2020.04.006
    引用本文: 陈治宇, 黎莹. 强强联合,持久获益——系统性治疗失败的MSI-H/dMMR转移性结直肠癌的免疫联合治疗[J]. 循证医学, 2020, 20(4): 222-226. DOI: 10.12019/j.issn.1671-5144.2020.04.006
    shu
    CHEN Zhi-yu, LI Ying. Strong Combination, Long-Lasting Benefit: Immunotherapy Combination for MSI-H/dMMR Metastatic Colorectal Cancer That Has Failed Systemic Treatment[J]. Journal of Evidence-Based Medicine, 2020, 20(4): 222-226. DOI: 10.12019/j.issn.1671-5144.2020.04.006
    Citation: CHEN Zhi-yu, LI Ying. Strong Combination, Long-Lasting Benefit: Immunotherapy Combination for MSI-H/dMMR Metastatic Colorectal Cancer That Has Failed Systemic Treatment[J]. Journal of Evidence-Based Medicine, 2020, 20(4): 222-226. DOI: 10.12019/j.issn.1671-5144.2020.04.006
    shu

    强强联合,持久获益——系统性治疗失败的MSI-H/dMMR转移性结直肠癌的免疫联合治疗

    Strong Combination, Long-Lasting Benefit: Immunotherapy Combination for MSI-H/dMMR Metastatic Colorectal Cancer That Has Failed Systemic Treatment

      摘要
      • HTML全文
      • 参考文献(13)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回